2m 2m 2m 2m 2m 2m 2m
Fulgent Genetics (FLGT)
NASDAQ
$20.46+$0.005 (+0.02%)
Price as of Sep 11, 2026 7:30 PM EDT- $562.7MMarket Cap
- -6.54%1-Year Change
- Diagnostics & ResearchIndustry
Fulgent Genetics (FLGT)
$20.46+$0.005 (+0.02%)
FLGT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $20.45 | ||
Change | +$0.33 (+1.64%) | ||
Open | $20.30 | ||
High | $20.52 | ||
Low | $19.86 | ||
Previous Close | $20.12 | ||
Volume | 380,484 | ||
30-Day Average Volume | 262,670 | ||
1-Week Change | 3.65% | ||
1-Month Change | 7.63% | ||
1-Year Change | -6.54% | ||
3-Year Change | -33.41% | ||
5-Year Change | -78.17% | ||
Fundamentals | |||
Shares Outstanding | 27.5M | ||
Total Assets | $1.1B | ||
Market Cap | $562.7M | ||
Enterprise Value | $540.3M | ||
Period: QTR TTM FY | |||
Revenue | $85.4M | ||
Net Income | -$29.5M | ||
Free Cash Flow | -$27.6M | ||
EBIT | -$29.5M | ||
EBITDA | -$21.8M | ||
Net Working Capital | $383.0M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -24 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue